Related Experiment Video
Updated: Jan 4, 2026

09:51
Enhanced Genome Editing with Cas9 Ribonucleoprotein in Diverse Cells and Organisms
Published on: May 25, 2018
35.3K
A glance at genome editing with CRISPR-Cas9 technology
Antara Barman1, Bornali Deb1, Supriyo Chakraborty2
1Department of Biotechnology, Assam University, Silchar, Silchar, Assam, 788011, India.
Current Genetics
|November 7, 2019
Summary
CRISPR-Cas9 gene editing technology offers revolutionary potential for treating diseases and improving crops. This review explores its mechanisms, applications, and safety for accurate genome modification.
Area of Science:
- Biotechnology
- Molecular Biology
- Genetics
Background:
- CRISPR-Cas9 is a prokaryotic adaptive immunity system targeting foreign nucleic acids.
- The Cas9 nuclease precisely cleaves DNA, enabling targeted genome editing.
- This technology has broad applications in medicine, agriculture, and genetic research.
Purpose of the Study:
- To review the CRISPR-Cas9 system's architecture, mechanism, and repair pathways.
- To discuss strategies for enhancing Cas9 specificity and reducing off-target effects.
- To explore CRISPR tools, databases, delivery methods, and diverse applications.
Main Methods:
- Review of CRISPR-Cas9 organization into two classes with distinct effectors.
- Analysis of CRISPR loci architecture and genome editing mechanisms.
- Examination of double-strand break repair pathways and specificity enhancement strategies.
Main Results:
- CRISPR-Cas9 technology enables precise genome editing across various organisms.
- Strategies exist to improve specificity and minimize off-target mutations.
- The review covers essential tools, databases, delivery systems, and applications.
Conclusions:
- CRISPR-Cas9 is a powerful tool for genetic manipulation with vast therapeutic and agricultural potential.
- Ensuring specificity and addressing ethical concerns are crucial for responsible application.
- Future prospects include treating genetic diseases, enhancing crops, and advancing human genetics.
Related Concept Videos
CRISPR
57.3K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
57.3K
CRISPR/Cas9 Genome Editing
1.5K
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
1.5K
CRISPR and crRNAs
18.6K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
18.6K
Homologous Recombination
62.2K
The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
62.2K

